The Platform That Our Clients Have Combined To Create Has Completely Changed The Way That Healthcare Practices Are Bought And Sold.
THIS PLATFORM WILL BE THE PLATFORM THROUGH WHICH ALL (OR A VAST MAJORITY) OF HEALTHCARE PRACTICES WILL BE BOUGHT AND SOLD, MOVING FORWARD.
Healthcare practices have traditionally been sold the same way for decades. A practice profile is completed and then the Doctor or broker calls up buyers one at a time to ascertain interest. The back-and-forth negotiations then begin and a sale may or may not be ultimately consummated. The process has been painfully slow.
Our clients have invested millions into creating a platform that simultaneously presents a completed Healthcare practice profile to over 1,000 private buyers (interested in healthcare) as well as to over 4,000 publicly traded companies that could be interested in one practice or in a large number of practices for purchase (i.e. rollup or related scenario). The Seller defines (within their profile) the conditions under which they are willing to sell and therefore only buyers who are willing to accept those conditions, respond with offers. The timeline, in terms of sale, is therefore significantly reduced.
Doctors maintain complete anonymity during the sales process (patients and staff do not need to know) and, as stated, the Doctor defines the parameters (conditions) under which they will agree to sell. These parameters are part of the package presented so only serious buyers (who agree with the conditions of sale) respond with offers. Many of the buyers on the platform are also different from the standard MSO or DSO in that they are not interested in running the day-to-day operations of a practice. These buyers allow the practice owner to maintain autonomy over the practice post sale.
We Encourage Any Doctor Who Is Interested In Selling All Or Part Of Their Practice Within The Next 5 Years, To Speak With Our Clients. We Encourage Them To Evaluate Whether This Proprietary, AI Driven Approach Makes Sense For Their Practice, For Their Patients And For Themselves Personally.
Our Client’s Program Simultaneously Exposes A Practice’s Completed Profile To Over 1,000 Private Buyers and To Over 4,000 Public Companies (Instead Of To Buyers One At A Time).
Millions in development went into the creation of our client’s platform that boasts over 1,000 private buyers interested in healthcare and over 4,000 publicly traded companies.
Every practice that is presented on the platform receives multiple offers.
Our Client’s Platform Is Unique And Proprietary. There Is Nothing Else Like It Available To The Practice Owner.
As stated, millions went into platform development and years were spent recruiting the buyers who review and purchase the practices presented. Our client does SEC and HIPAA compliance for over 4,000 publicly traded companies worldwide which has created a unique pipeline to Public Companies interested (through a number of different structures) in acquiring Healthcare practices. This platform is the only platform available in healthcare that has organized private and public buyers so that a seller’s practice can be reviewed and purchased efficiently and at the highest sales price possible.
Profiles Are Properly Prepared And Are “Deal Ready”
Many buyers will not even review practice profiles created by many brokers. They know that the profiles will not be in the format where they are “deal ready”. Our client has hired Merger & Acquisition Specialists from Goldman Sachs and others who prepare “deal ready” profiles for all practices on the platform – regardless of size. This level of expertise is usually reserved for 20+ million dollar deals but is now available to all practices. Buyers review the profiles because they know that the profiles will be prepared correctly and will be "deal ready".
Practices Receive A Much Higher Sales Price Because The Practices Are Prepared Correctly And They Are Exposed To A Much Larger Pool Of Buyers Who Are Buying For A Diverse Number Of Reasons.
The DSO and MSO monopoly, in terms of this space, has ended. Buyers through this platform pay multiples of EBITDA and/or of gross revenue that are many times at 3x gross or greater (sometimes much greater). Practices should never again have to settle for .7x gross from a DSO or MSO.